These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12573412)

  • 21. Debate on essential medicines heats up.
    Kapp C
    Lancet Infect Dis; 2001 Nov; 1(4):215. PubMed ID: 11871503
    [No Abstract]   [Full Text] [Related]  

  • 22. Why adopt a maximin theory of exploitation?
    Wertheimer A; Millum J; Schaefer GO
    Am J Bioeth; 2010 Jun; 10(6):38-9. PubMed ID: 20526968
    [No Abstract]   [Full Text] [Related]  

  • 23. National health research system mapping in 10 Eastern Mediterranean countries.
    Kennedy A; Khoja TA; Abou-Zeid AH; Ghannem H; IJsselmuiden C;
    East Mediterr Health J; 2008; 14(3):502-17. PubMed ID: 18720615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suitable monitoring approaches to antiretroviral therapy in resource-poor settings: setting the research agenda.
    Kent DM; McGrath D; Ioannidis JP; Bennish ML
    Clin Infect Dis; 2003 Jul; 37(Suppl 1):S13-24. PubMed ID: 12822128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antiretroviral treatment in resource-poor settings: public health research priorities.
    Jaffar S; Govender T; Garrib A; Welz T; Grosskurth H; Smith PG; Whittle H; Bennish ML
    Trop Med Int Health; 2005 Apr; 10(4):295-9. PubMed ID: 15807791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WHO launches guidelines to speed up delivery of antiretroviral drugs to HIV/AIDS patients.
    Bull World Health Organ; 2003; 81(11):852-3. PubMed ID: 14758421
    [No Abstract]   [Full Text] [Related]  

  • 27. Early versus deferred antiretroviral therapy in children in low-income and middle-income countries.
    Puthanakit T; Bunupuradah T
    Curr Opin HIV AIDS; 2010 Jan; 5(1):12-7. PubMed ID: 20046143
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Justice in the application of science: beyond fair benefits.
    London AJ
    Am J Bioeth; 2010 Jun; 10(6):54-6. PubMed ID: 20526976
    [No Abstract]   [Full Text] [Related]  

  • 29. For-profit clinical trials in developing countries--those troublesome patient benefits.
    Schuklenk U
    Am J Bioeth; 2010 Jun; 10(6):52-4. PubMed ID: 20526975
    [No Abstract]   [Full Text] [Related]  

  • 30. Joint European plan will tackle Africa's killer diseases.
    McDowell N
    Nature; 2003 Jan; 421(6918):5. PubMed ID: 12511923
    [No Abstract]   [Full Text] [Related]  

  • 31. One size does not fit all: toward "upstream ethics"?
    Ozdemir V; Knoppers BM
    Am J Bioeth; 2010 Jun; 10(6):42-4. PubMed ID: 20526970
    [No Abstract]   [Full Text] [Related]  

  • 32. HIV/AIDS. International AIDS meeting finds global commitment lacking.
    Cohen J
    Science; 2004 Jul; 305(5683):470-1. PubMed ID: 15273375
    [No Abstract]   [Full Text] [Related]  

  • 33. The assessment of dermatological needs in resource-poor regions.
    Hay RJ; Fuller LC
    Int J Dermatol; 2011 May; 50(5):552-7. PubMed ID: 21506971
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opportunities and options for treatment research in resource-constrained settings.
    Volberding PA
    Clin Infect Dis; 2003 Jul; 37(Suppl 1):S1-3. PubMed ID: 12822126
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From Bangkok to Mexico: towards a framework for turning knowledge into action to improve health systems.
    Pang T; Pablos-Mendez A; IJsselmuiden C
    Bull World Health Organ; 2004 Oct; 82(10):720-1. PubMed ID: 15643788
    [No Abstract]   [Full Text] [Related]  

  • 36. Microbicides. Raising new barriers against HIV infection.
    Trager RS
    Science; 2003 Jan; 299(5603):39. PubMed ID: 12511630
    [No Abstract]   [Full Text] [Related]  

  • 37. HIV resistance and the developing world.
    Gupta RK; Pillay D
    Int J Antimicrob Agents; 2007 May; 29(5):510-7. PubMed ID: 17346940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dispatches from the front line.
    Nature; 2002 Aug; 418(6897):465. PubMed ID: 12152038
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiretroviral treatment for HIV infection in developing countries: an attainable new paradigm.
    Moatti JP; N'Doye I; Hammer SM; Hale P; Kazatchkine M
    Nat Med; 2003 Dec; 9(12):1449-52. PubMed ID: 14647513
    [No Abstract]   [Full Text] [Related]  

  • 40. Poverty and health sector inequalities.
    Wagstaff A
    Bull World Health Organ; 2002; 80(2):97-105. PubMed ID: 11953787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.